Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment

BACKGROUND: Common variable immunodeficiency disorders (CVID), the most common form of primary antibody deficiency, are rare conditions associated with considerable morbidity and mortality. The clinical benefit of immunoglobulin replacement therapy (IgGRT) is substantial: timely treatment with appro...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wilder, Philippe, Odnoletkova, Irina, Mouline, Mehdi, de Vries, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932530/
https://www.ncbi.nlm.nih.gov/pubmed/33661975
http://dx.doi.org/10.1371/journal.pone.0247941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932530/
https://www.ncbi.nlm.nih.gov/pubmed/33661975
http://dx.doi.org/10.1371/journal.pone.0247941

Ejemplares similares